Neuroendocrine Carcinoma of the CervixSymptoms, Doctors, Treatments, Advances & More
Learn About Neuroendocrine Carcinoma of the Cervix
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Advocate Lutheran General Cancer Institute
Timothy Lestingi is a Hematologist and an Oncologist practicing medicine in Park Ridge, Illinois. Dr. Lestingi is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Ureteroscopy, and Gastrostomy. Dr. Lestingi is board certified in American Board Of Internal Medicine, Medical Oncology.
Lynda Roman is an Oncologist practicing medicine in Tarzana, California. Dr. Roman is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Cervical Cancer, Ovarian Cancer, Hysterectomy, and Oophorectomy. Dr. Roman is currently accepting new patients.
UT MD Anderson Cancer Center
Anuja Jhingran is a Radiation Oncologist practicing medicine in Cary, North Carolina. Dr. Jhingran is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Endometrial Cancer, and Vaginal Cancer.
Summary: This study collects information and data on patients with neuroendocrine cervical cancer. Information from this study may be used to better understand the correlation between clinical data, such as patient characteristics, treatment, and disease outcomes, and overall patient outcomes.
Summary: This study is a single arm, exploratory clinical study aimed at evaluating the efficacy and safety of karelizumab combined with etoposide and cisplatin in the neoadjuvant treatment of neuroendocrine cervix carcinoma.